Table 2.
Disability | ||||||||
---|---|---|---|---|---|---|---|---|
Univariable | Model 1 | Model 2 | Model 3 | |||||
ß (SE) | p | ß (SE) | p | ß (SE) | p | ß (SE) | p | |
Baseline psychiatric status | ||||||||
Healthy controls | Ref | Ref | Ref | Ref | ||||
SAD | 15.28 (1.55) | <.001 | 14.26 (1.74) | <.001 | 5.09 (1.42) | <.001 | 4.38 (1.55) | <.001 |
SAD x time | -6.48 (0.61) | <.001 | -6.40 (0.61) | <.001 | -2.52 (0.57) | .01 | -2.56 (0.57) | .01 |
PDA | 9.31 (2.09) | <.001 | 9.54 (2.24) | <.001 | -0.46 (1.88) | .65 | -0.65 (1.98) | .52 |
PDA x time | -4.18 (0.85) | <.001 | -4.04 (0.85) | <.001 | -0.07 (0.77) | .94 | -0.11 (0.77) | .92 |
PD | 5.96 (2.15) | <.001 | 6.40 (2.29) | <.001 | 0.46 (1.84) | .65 | 0.23 (1.94) | .82 |
PD x time | -1.43 (0.88) | .15 | -1.29 (0.88) | .20 | -0.07 (0.77) | .95 | -0.11 (0.77) | .92 |
GAD | 13.01 (1.93) | <.001 | 13.19 (2.07) | <.001 | 6.62 (1.68) | <.001 | 6.07 (1.77) | <.001 |
GAD x time | -5.80 (0.79) | <.001 | -5.58 (0.80) | <.001 | -3.52 (0.70) | <.001 | -3.55 (0.70) | <.001 |
Multiple AD | 20.93 (1.57) | <.001 | 18.21 (1.58) | <.001 | 3.58 (1.46) | <.001 | 3.00 (1.58) | .003 |
Multiple AD x time | -7.61 (0.54) | <.001 | -7.54 (0.54) | <.001 | -1.31 (0.58) | .19 | -1.36 (0.58) | .18 |
Psychiatric course trajectory | ||||||||
Healthy controls | Ref | Ref | Ref | |||||
Remission | 10.30 (0.82) | <.001 | -3.12 (1.12) | .002 | 0.63 (0.84) | .53 | ||
Recurrence | 7.82 (1.66) | <.001 | -0.01 (1.70) | .99 | 0.42 (1.23) | .67 | ||
Chronic course | 14.65 (1.32) | <.001 | 3.65 (1.48) | <.001 | 0.94 (1.08) | .35 | ||
Symptom dimensions | ||||||||
Anxiety arousal | 24.28 (0.04) | <.001 | 12.49 (0.06) | <.001 | 12.51 (0.06) | <.001 | ||
Anxiety arousal x time | 1.49 (0.02) | .14 | 0.90 (0.03) | .37 | 0.86 (0.03) | .39 | ||
Avoidance behaviour | 23.28 (0.02) | <.001 | 10.58 (0.03) | <.001 | 10.57 (0.03) | <.001 | ||
Avoidance behaviour x time | -1.40 (0.01) | .16 | 0.17 (0.01) | .87 | 0.14 (0.01) | .89 |
aAnalyses corrected for covariates age, sex, education, partner status, number of somatic illnesses and comorbid depression
Model 1: baseline psychiatric status and course trajectories; Model 2: baseline psychiatric status and symptom dimensions; Model 3: final model